Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Merhaki Foods & Nutrition is an Indian consumer healthcare company specializing in nutritional supplements tailored for women's health. The company's flagship brand, i-SAY, provides plant-based, science-backed solutions for managing Polycystic Ovary Syndrome (PCOS) and related hormonal issues. Merhaki focuses on bridging the gap in the nutraceutical market by offering products that combine traditional knowledge with modern clinical research. In April 2022, the company was acquired by Cipla Health Limited, a subsidiary of the pharmaceutical major Cipla. This strategic acquisition integrated Merhaki's specialized portfolio into Cipla's broader consumer wellness segment, enhancing its presence in the rapidly growing women's healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Merhaki Foods & Nutrition.